Summary of cell homing to the murine BM 48 hours after tail vein injection
Injected cell dose . | Human engraftment, %* . | BM homing at 48 hours, no./no. total (%) . |
---|---|---|
105 ALDHhiCD133-Lin- | 0, 0, 0, 0 | 0/5 (0) |
2 × 105 ALDHhiCD133-Lin- | 0, 0, 0 | 0/3 (0) |
4 × 105 ALDHhiCD133-Lin- | 0, 0 | 0/2 (0) |
105 ALDHhiCD133+Lin- | 0, 0, 0.2, 0.2, 0.3 | 3/5 (60) |
2 × 105 ALDHhiCD133+Lin- | 0.2, 0.3, 0.3, 0.4 | 4/4 (100) |
4 × 105 ALDHhiCD133+Lin- | 0.3, 0.4 | 2/2 (100) |
4 × 105 Lin- | 0, 0, 0.4 | 1/3 (33) |
Injected cell dose . | Human engraftment, %* . | BM homing at 48 hours, no./no. total (%) . |
---|---|---|
105 ALDHhiCD133-Lin- | 0, 0, 0, 0 | 0/5 (0) |
2 × 105 ALDHhiCD133-Lin- | 0, 0, 0 | 0/3 (0) |
4 × 105 ALDHhiCD133-Lin- | 0, 0 | 0/2 (0) |
105 ALDHhiCD133+Lin- | 0, 0, 0.2, 0.2, 0.3 | 3/5 (60) |
2 × 105 ALDHhiCD133+Lin- | 0.2, 0.3, 0.3, 0.4 | 4/4 (100) |
4 × 105 ALDHhiCD133+Lin- | 0.3, 0.4 | 2/2 (100) |
4 × 105 Lin- | 0, 0, 0.4 | 1/3 (33) |
Each value represents one of the mice tested